Cellcare Pathology Lab Profile
Key Indicators
- Authorised Capital ₹ 4.10 M
as on 16-12-2024
- Paid Up Capital ₹ 4.10 M
as on 16-12-2024
- Company Age 11 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 9.30 M
as on 16-12-2024
- Revenue 39.35%
(FY 2021)
- Profit 113.67%
(FY 2021)
- Ebitda 35.44%
(FY 2021)
- Net Worth 47.09%
(FY 2021)
- Total Assets 24.99%
(FY 2021)
About Cellcare Pathology Lab
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 4.10 M and a paid-up capital of Rs 4.10 M.
The company currently has active open charges totaling ₹9.30 M.
Swapan Desai, Vipul Patel, Dhyanesh Desai, and One other member serve as directors at the Company.
- CIN/LLPIN
U74140GJ2013PTC074340
- Company No.
074340
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
03 Apr 2013
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Cellcare Pathology Lab?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Swapan Desai  | Director | 03-Apr-2013 | Current |
| Vipul Patel | Director | 03-Apr-2013 | Current |
| Dhyanesh Desai | Director | 10-Mar-2014 | Current |
| Sandeep Sheth | Director | 03-Apr-2013 | Current |
Financial Performance of Cellcare Pathology Lab.
Cellcare Pathology Lab Private Limited, for the financial year ended 2021, experienced significant growth in revenue, with a 39.35% increase. The company also saw a substantial improvement in profitability, with a 113.67% increase in profit. The company's net worth Soared by an impressive increase of 47.09%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Cellcare Pathology Lab?
In 2019, Cellcare Pathology Lab had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Cellcare Anand Pathology Lab Private LimitedActive 1 year 11 monthsSwapan Desai and Dhyanesh Desai are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Textile Traders Co Operative Bank Limited Creation Date: 07 Aug 2015 | ₹1.80 M | Open |
Textile Traders Co-Operative Bank Limited Creation Date: 18 Oct 2013 | ₹1.50 M | Open |
Textile Traders Co-Operative Bank Ltd. Creation Date: 06 Aug 2013 | ₹6.00 M | Open |
How Many Employees Work at Cellcare Pathology Lab?
Cellcare Pathology Lab has a workforce of 8 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Cellcare Pathology Lab, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Cellcare Pathology Lab's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
